Compare · MDLN vs SI
MDLN vs SI
Side-by-side comparison of Medline Inc. (MDLN) and Shoulder Innovations Inc. (SI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and SI operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 125.7x SI ($382.4M).
- Both names hit the wire about 7 times in the past 4 weeks.
- Both have 25 recent analyst ratings on file.
- Company
- Medline Inc.
- Shoulder Innovations Inc.
- Price
- -
- -
- Market cap
- $48.08B
- $382.4M
- 1M return
- -
- +2.00%
- 1Y return
- -
- +44.94%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- 2025
- News (4w)
- 7
- 7
- Recent ratings
- 25
- 25
Shoulder Innovations Inc.
Silvergate Capital Corporation operates as a bank holding company for Silvergate Bank that provides banking products and services to business and individual clients in the United States and internationally. The company accepts deposit products, including interest and noninterest bearing demand accounts, money market and savings accounts, and certificates of deposit accounts. Its loan products comprise one-to-four family real estate loans, multi-family real estate loans, commercial real estate loans, construction loans, commercial and industrial loans, mortgage warehouse loans, and reverse mortgage loans, as well as consumer loans and other loans secured by personal property. The company also provides cash management services for digital currency-related businesses. The company was founded in 1988 and is headquartered in La Jolla, California.
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M
Latest SI
- Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026
- SEC Form 8-K filed by Shoulder Innovations Inc.
- Shoulder Innovations Initiates Commercial Launch of the InSet® Go
- SEC Form 4 filed by Shoulder Innovations Inc.
- SEC Form 4 filed by Shoulder Innovations Inc.
- SEC Form 4 filed by Shoulder Innovations Inc.
- SEC Form 4 filed by Shoulder Innovations Inc.
- CEO & Executive Chairman Ball Robert Joseph exercised 89,233 shares at a strike of $2.10 and sold $187,706 worth of shares (10,175 units at $18.45), increasing direct ownership by 26% to 380,824 units (SEC Form 4)
- Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch
- Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures